Mr. Guy L. Peeples, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 604 N Spring St, Harrison, AR 72601 Phone: 870-741-6418 Fax: 870-741-5071 |
Dr. Thomas Richard Hoberock, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3213 Hwy 392 W, Harrison, AR 72601 Phone: 870-741-7331 |
Mr. Andrew L. Coble, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 604 N Spring Street, Harrison, AR 72601 Phone: 870-741-6418 Fax: 870-741-5071 |
Eric Duffey Graham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 604 N. Spring Street, Harrison, AR 72601 Phone: 870-741-6418 Fax: 870-741-5071 |
News Archive
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's ZofranĀ® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States.
University of Michigan-led research brings scientists one step closer to understanding the development of neurodegenerative disorders such as ALS.
New research from the University of Michigan School of Public Health found BPA, or bisphenol A, in fetal liver tissue, demonstrating that there is considerable exposure to the chemical during pregnancy.
› Verified 3 days ago